Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roman Osman

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Proteins|October 7, 2019
In silico design and molecular basis for the selectivity of Olinone toward the first over the second bromodomain of BRD4Yoel Rodríguez, Guillermo Gerona-Navarro, Roman Osman, et al.
Seminars in Hematology|November 23, 2024
Melanoma antigen genes (MAGE); novel functional targets in multiple myelomaAnna Huo-Chang Mei, Alessandro Laganà, Roman Osman, et al.
Journal of Autoimmunity|January 26, 2020
Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' diseaseCheuk Wun Li, Roman Osman, Francesca Menconi, et al.
Journal of Autoimmunity|September 28, 2016
Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetesCheuk Wun Li, Roman Osman, Francesca Menconi, et al.
Current Pharmaceutical Design|December 16, 2006
The heterodimeric sweet taste receptor has multiple potential ligand binding sitesMeng Cui, Peihua Jiang, Emeline Maillet, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2008
Autoinhibitory regulation of SCF-mediated ubiquitination by human cullin 1's C-terminal tailKosj Yamoah, Taiji Oashi, Antonio Sarikas, et al.
Molecular Pharmacology|August 13, 2004
A model of inverse agonist action at thyrotropin-releasing hormone receptor type 1: role of a conserved tryptophan in helix 6Xinping Lu, Wei Huang, Sharon Worthington, et al.
Journal of Autoimmunity|September 21, 2020
Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetesAngela Lombardi, Erlinda Concepcion, Hanxi Hou, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2010
Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditisFrancesca Menconi, Roman Osman, Maria C Monti, et al.
Thyroid : Official Journal of the American Thyroid Association|February 10, 2023
Effective Inhibition of Thyroid Antigen Presentation Using Retro-Inverso Peptides in Experimental Autoimmune Thyroiditis: A Pathway Toward Immune Therapies of Thyroid AutoimmunityCheuk Wun Li, Roman Osman, Francesca Menconi, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Proteins|October 7, 2019
In silico design and molecular basis for the selectivity of Olinone toward the first over the second bromodomain of BRD4Yoel Rodríguez, Guillermo Gerona-Navarro, Roman Osman, et al.
Seminars in Hematology|November 23, 2024
Melanoma antigen genes (MAGE); novel functional targets in multiple myelomaAnna Huo-Chang Mei, Alessandro Laganà, Roman Osman, et al.
Journal of Autoimmunity|January 26, 2020
Cepharanthine blocks TSH receptor peptide presentation by HLA-DR3: Therapeutic implications to Graves' diseaseCheuk Wun Li, Roman Osman, Francesca Menconi, et al.
Journal of Autoimmunity|September 28, 2016
Flexible peptide recognition by HLA-DR triggers specific autoimmune T-cell responses in autoimmune thyroiditis and diabetesCheuk Wun Li, Roman Osman, Francesca Menconi, et al.
Current Pharmaceutical Design|December 16, 2006
The heterodimeric sweet taste receptor has multiple potential ligand binding sitesMeng Cui, Peihua Jiang, Emeline Maillet, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2008
Autoinhibitory regulation of SCF-mediated ubiquitination by human cullin 1's C-terminal tailKosj Yamoah, Taiji Oashi, Antonio Sarikas, et al.
Molecular Pharmacology|August 13, 2004
A model of inverse agonist action at thyrotropin-releasing hormone receptor type 1: role of a conserved tryptophan in helix 6Xinping Lu, Wei Huang, Sharon Worthington, et al.
Journal of Autoimmunity|September 21, 2020
Retro-inverso D-peptides as a novel targeted immunotherapy for Type 1 diabetesAngela Lombardi, Erlinda Concepcion, Hanxi Hou, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 15, 2010
Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditisFrancesca Menconi, Roman Osman, Maria C Monti, et al.
Thyroid : Official Journal of the American Thyroid Association|February 10, 2023
Effective Inhibition of Thyroid Antigen Presentation Using Retro-Inverso Peptides in Experimental Autoimmune Thyroiditis: A Pathway Toward Immune Therapies of Thyroid AutoimmunityCheuk Wun Li, Roman Osman, Francesca Menconi, et al.
Pageof 5